Dr. Pal on the Frontline Approval of Nivolumab and Ipilimumab in mRCC OncLive 0:51 6 years ago 253 Далее Скачать
FDA Approval of Frontline Nivolumab/Ipilimumab Combo in RCC OncLive 1:34 6 years ago 926 Далее Скачать
Front-line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced RCC VJOncology 8:26 4 years ago 224 Далее Скачать
Dr. McKay on FDA Approval of Nivolumab/Ipilimumab in Frontline RCC OncLive 0:52 7 years ago 196 Далее Скачать
Dr. Pal on the Rationale for the TIVO-3 Trial With Tivozanib in Advanced RCC OncLive 0:52 4 years ago 136 Далее Скачать
Dr. Eng on the FDA Approval of Nivolumab Plus Ipilimumab in CRC OncLive 0:43 6 years ago 337 Далее Скачать
Dr. Rosenberg on Dosing of Nivolumab Plus Ipilimumab in Bladder Cancer OncLive 0:53 6 years ago 271 Далее Скачать
Dr. Pal on Preoperative Immunotherapy in Patients With RCC OncLive 0:48 7 years ago 125 Далее Скачать
Dr. Pal on Sequencing Challenges for the Treatment of Patients With RCC OncLive 1:01 8 years ago 109 Далее Скачать
